Relay Therapeutics, Inc.
RLAY
Peringkat dalam Saham
#4008
Relay Therapeutics, Inc. is a precision medicine company currently engaged in... Relay Therapeutics, Inc. is a precision medicine company currently engaged in clinical trials. Its central mission involves revolutionizing the drug discovery process, with a particular focus on enhancing the creation of small molecule therapies for specific types of cancer and genetic conditions. The company's pipeline features several promising drug candidates: RLY-4008, an orally administered small molecule designed to inhibit fibroblast growth factor receptor 2 (FGFR2), which is undergoing its initial human trials for patients with advanced or metastatic solid tumors exhibiting FGFR2 alterations; RLY-2608, a leading program targeting mutant phosphoinositide 3 kinase alpha (PI3Ka); and RLY-1971, another oral small molecule, an inhibitor of SHP2 (protein tyrosine phosphatase Src homology region 2 domain-containing phosphatase-2), currently in Phase 1 trials for individuals with advanced solid tumors. Relay Therapeutics has established strategic partnerships, including a collaboration with D. E. Shaw Research, LLC, which utilizes computational modeling to analyze protein motion for the identification and development of therapeutic compounds. Furthermore, an agreement with Genentech, Inc. supports the development and commercialization of RLY-1971. Founded in 2015 as Allostery, Inc., the company rebranded to Relay Therapeutics, Inc. in December of that year and maintains its headquarters in Cambridge, Massachusetts.
Harga Saham
$18.65
Kapitalisasi Pasar
$4.09B
Perubahan (1 hari)
9.15%
Perubahan (1 tahun)
161.25%
Negara
US
Perdagangan Relay Therapeutics, Inc. (RLAY)
Kategori
Healthcare
Jumlah saham beredar untuk Relay Therapeutics, Inc. (RLAY)
Jumlah saham beredar per June 2026: 202.85M
Menurut laporan keuangan terbaru dan harga saham Relay Therapeutics, Inc., jumlah saham beredar saat ini adalah 202.85M. Pada akhir December 2023, perusahaan memiliki 122.58M saham beredar. Jumlah saham beredar biasanya dipengaruhi oleh pemecahan saham dan pembelian kembali saham.
Riwayat saham beredar untuk Relay Therapeutics, Inc. (RLAY) dari 2018 hingga 2026
Saham beredar pada akhir setiap tahun
| Tahun | Saham Beredar | Mengubah |
|---|---|---|
| 2026 (TTM) | 202.85M | 41.98% |
| 2024 | 142.87M | 16.55% |
| 2023 | 122.58M | 9.22% |
| 2022 | 112.23M | 17.97% |
| 2021 | 95.14M | 5.65% |
| 2020 | 90.05M | 2,003.45% |
| 2019 | 4.28M | 72.27% |
| 2018 | 2.49M | 0.00% |
Saham beredar untuk perusahaan serupa atau pesaing
| Perusahaan | Saham Beredar | Perbedaan | Negara |
|---|---|---|---|
| 253.90M | 25.17% |
US
|
|
| 396.00M | 95.22% |
US
|
|
| 478.91M | 136.09% |
AU
|
|
| - | - |
CH
|
|
| 62.19M | -69.34% |
NL
|
